DXCM
DexCom Inc
NASDAQ: DXCM · HEALTHCARE · MEDICAL DEVICES
$57.56
-2.97% today
Updated 2026-04-29
Market cap
$22.21B
P/E ratio
27.54
P/S ratio
4.76x
EPS (TTM)
$2.09
Dividend yield
—
52W range
$54 – $90
Volume
4.1M
DexCom Inc (DXCM) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-19.8%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.1%
Last 4 reports
Positive reaction rate
25%
1 of 4 quarters
Largest single-day move
-14.6%
2025-10-30
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-23 | $0.00 | -100.0% | $63.41 | $61.57 | -2.9% |
| 2026-02-12 | $0.68 | +4.6% | $68.15 | $70.02 | +2.7% |
| 2025-10-30 | $0.61 | +7.0% | $68.18 | $58.22 | -14.6% |
| 2025-07-30 | $0.48 | +9.1% | $89.35 | $80.77 | -9.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $0.47 | $0.00 | -100.0% | — | — |
| 2025-12-31 | $0.65 | $0.68 | +4.6% | $1.26B | +13.1% |
| 2025-09-30 | $0.57 | $0.61 | +7.0% | $1.21B | +21.6% |
| 2025-06-30 | $0.44 | $0.48 | +9.1% | $1.16B | +15.2% |
| 2025-03-31 | $0.33 | $0.32 | -3.0% | $1.04B | +12.5% |
| 2024-12-31 | $0.48 | $0.38 | -20.8% | $1.11B | +7.6% |
| 2024-09-30 | $0.43 | $0.45 | +4.7% | $994.20M | +2.0% |
| 2024-06-30 | $0.39 | $0.43 | +10.3% | $1.00B | — |
| 2024-03-31 | $0.27 | $0.32 | +18.5% | $921.00M | — |
| 2023-12-31 | $0.43 | $0.50 | +16.3% | $1.03B | — |
| 2023-09-30 | $0.34 | $0.50 | +47.1% | $975.00M | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $2.54 | $5.3B | +14.5% | 21 | high |
| 2027 (E) | $3.04 | $6.0B | +12.4% | 21 | high |
| 2029 (E) | $4.29 | $7.6B | +12.4% | 21 | medium |
| 2030 (E) | $4.95 | $8.5B | +12.2% | 21 | medium |
Frequently asked questions
Has DexCom Inc beaten earnings estimates?
DexCom Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -19.8% over the last 4 quarters.
How does DXCM stock react to earnings?
DXCM stock has moved an average of -6.1% in the trading day following earnings over its last 4 reports, with positive reactions in 25% of those quarters.
What is the expected EPS for DXCM in 2026?
Analysts expect DexCom Inc to report EPS of $2.54 for fiscal year 2026, on revenue of $5.3B, based on estimates from 21 analysts.